Last edition
News about "AI-powered drug development"
Parexel Launches ParexelAI to Speed Up Clinical Development
Parexel launches ParexelAI, a proprietary Artificial Intelligence (AI) platform designed to accelerate clinical development by improving trial speed, efficiency, and data quality for sponsors and patients.
AI-powered Drug Development | 20/05/2026 | By News Bureau
Dyno Therapeutics Unveils Next-Generation AI-Engineered AAV Capsids for CNS and Muscle Gene Delivery
Dyno Therapeutics introduced new AAV gene delivery capsids for central nervous system and muscular applications, highlighting enhanced cross-species transduction, reduced liver targeting and scalable manufacturing potential for next-generation genetic medicines.
AI-powered Drug Development | 16/05/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy